Packaging | June 09, 2024
Syntegon acquires Telstar
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
This strategic decision will unlock significant value for our scientific and industrial products business
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
This novel recombinant has been developed and is a patented novel recombinant Human Albumin 20% process
The state-of-the-art facility is equipped with best-in-class equipment and control systems
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
Facility in The Woodlands, Texas to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025
PIVOTAL is an open label, randomized, multicenter, Phase III trial evaluating Nidlegy as a neoadjuvant intralesional therapy
Subscribe To Our Newsletter & Stay Updated
